Man Investments (UK)’s Biogen BIIB Stock Holding History

Man Investments (UK)’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-3,831	Closed	-$922K	–	618
2013 Q3	$922K	Buy	+3,831	New	+$857K	0.13%	303

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Man Investments (UK)'s BIIB Position: Q4 2013 in Review

Man Investments (UK) sold out of Biogen (BIIB) in Q4 2013, closing a stake of 3,831 shares — an estimated $922K sold.

Man Investments (UK) first reported a position in BIIB in Q3 2013 and held it in 1 quarter. The position peaked at $922K in Q3 2013. 738 funds tracked by Wall St. Rank hold BIIB as of Q4 2013.

Man Investments (UK) reported no remaining Biogen position as of Q4 2013 after selling out during the quarter.
Man Investments (UK) sold 3,831 Biogen shares in Q4 2013, an estimated $922K.
Man Investments (UK) first reported a position in Biogen in Q3 2013 and held it in 1 quarter.
Man Investments (UK)'s Biogen position peaked at $922K in Q3 2013.
738 funds tracked by Wall St. Rank held Biogen as of Q4 2013.

Based on Man Investments (UK)'s 13F filing for Q4 2013, filed 14 Feb 2014.